These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2694162)

  • 61. Retinoid chemoprevention timing and dose intensity.
    Band PR; Deschamps M; Israël L
    Cancer Invest; 1989; 7(2):205-10. PubMed ID: 2676088
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer.
    Miller WH
    Cancer; 1998 Oct; 83(8):1471-82. PubMed ID: 9781940
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of growth and development of the transplantable C-6 glioma cells inoculated in rats by retinoids and carotenoids.
    Wang CJ; Chou MY; Lin JK
    Cancer Lett; 1989 Nov; 48(2):135-42. PubMed ID: 2819700
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lycopene in the prevention of prostate cancer.
    Dahan K; Fennal M; Kumar NB
    J Soc Integr Oncol; 2008; 6(1):29-36. PubMed ID: 18302908
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chemoprevention in head and neck cancer.
    Heyne KE; Lippman SM; Hong WK
    Hematol Oncol Clin North Am; 1991 Aug; 5(4):783-95. PubMed ID: 1890067
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chemoprevention of oral squamous cell carcinomas.
    Scheer M; Kuebler AC; Zöller JE
    Onkologie; 2004 Apr; 27(2):187-93. PubMed ID: 15138354
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chemoprevention of lung cancer.
    Hong WK
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):135-41. PubMed ID: 10550838
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical pharmacology of 3 generations of retinoids.
    Vahlquist A; Rollman O
    Dermatologica; 1987; 175 Suppl 1():20-7. PubMed ID: 3319726
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Moving promising research findings to the clinic: methodological issues in the design and conduct of clinical trials of retinoids.
    Arnold A
    Int J Cancer; 1997 Feb; 70(4):467-9. PubMed ID: 9033656
    [No Abstract]   [Full Text] [Related]  

  • 70. The role of intervention studies in ascertaining the contribution of dietary factors in lung cancer. The Seattle chemoprevention trial of retinoids in asbestos-exposed workers.
    Omenn GS; Goodman GE; Kleinman GD; Rosenstock L; Barnhart S; Feigl P; Thomas DB; Kalman D; Lund B; Prentice RL
    Ann N Y Acad Sci; 1988; 534():575-83. PubMed ID: 3389681
    [No Abstract]   [Full Text] [Related]  

  • 71. Evolution of aerodigestive tract 13-cis-retinoid acid chemoprevention: the M.D. Anderson experience.
    Hong WK; Benner SE; Lippman SM
    Leukemia; 1994; 8 Suppl 3():S33-7. PubMed ID: 7808022
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Retinoids in cancer therapy and chemoprevention: promise meets resistance.
    Freemantle SJ; Spinella MJ; Dmitrovsky E
    Oncogene; 2003 Oct; 22(47):7305-15. PubMed ID: 14576840
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of chemoprevention in cancer control.
    Greenwald P; Kelloff GJ
    IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Importance of stratification in later stages of clinical trials.
    Durant JR; Bartolucci AA; Birch R
    Control Clin Trials; 1981 Dec; 2(4):319-25. PubMed ID: 7333107
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Statistical issues in the planning of prevention studies.
    Zelen M
    Cancer Invest; 1988; 6(5):615-20. PubMed ID: 3214765
    [No Abstract]   [Full Text] [Related]  

  • 77. Fei-Liu-Ping ointment inhibits lung cancer growth and invasion by suppressing tumor inflammatory microenvironment.
    Li W; Chen C; Saud SM; Geng L; Zhang G; Liu R; Hua B
    BMC Complement Altern Med; 2014 May; 14():153. PubMed ID: 24885825
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of serum and tissue pharmacology studies in the design and interpretation of chemoprevention trials.
    Plezia PM; Alberts DS; Peng YM; Xu MJ; Sayers S; Davis TP; Surwit EA; Meyskens FL
    Prev Med; 1989 Sep; 18(5):680-7. PubMed ID: 2694162
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Retinoids and carotenoids in cancer chemoprevention trials].
    Hattchouel JM; Laplanche A
    Bull Cancer; 1992; 79(10):957-62. PubMed ID: 1292762
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cancer chemoprevention. Part 1: Retinoids and carotenoids and other classic antioxidants.
    Singh DK; Lippman SM
    Oncology (Williston Park); 1998 Nov; 12(11):1643-53, 1657-8; discussion 1659-60. PubMed ID: 9834941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.